Sale

DNA Synthesizer Market

Global DNA Synthesizer Market Size, Share, Analysis, Demand, Report: By Type: Benchtop DNA Synthesizers, Large-scale DNA Synthesizers; By Application: Research and Development, Academic, Industrial, Diagnosis, Therapeutics; By End User; Market Dynamics; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global DNA Synthesizer Market Outlook

The global DNA synthesizer market size was valued at USD 261.06 million in 2023, driven by the increasing demand for efficient DNA synthesizers across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032 to achieve a value of USD 876.14 million by 2032.

 

DNA Synthesizer: Introduction

DNA synthesizers are devices that produce DNA molecules with a specific sequence of nucleotides. These molecules can be utilized to treat diseases by replacing damaged DNA with repaired sections. A DNA synthesizer is a crucial laboratory instrument used to chemically create or synthesize DNA molecules. It plays a vital role in molecular biology, genetics, and biotechnology research, as it enables scientists to design custom DNA sequences for different purposes, including cloning, gene expression studies, genetic engineering, and DNA sequencing.

 

Global DNA Synthesizer Market Analysis

The increasing demand for DNA synthesis technology is due to the widespread application in research to better understand the mechanisms of disease and in the drug discovery process to combat disease is a major trend influencing the market growth.

 

The continuous research and development activities by biotech firms and other institutions are also majorly contributing to the global DNA synthesizer market growth. For example, recently this year, Ansa Biotechnologies, Inc. claimed a successful creation of the world’s longest DNA oligonucleotide in a single synthesis. The 1005-base sequence codes for a key part of an adeno-associated virus vector used to develop gene therapy.

 

The market is experiencing heavy investments by synthetic biology companies that are interested in developing new technological advancements in this area, further expected to expand the market growth. For example, a UK-based synthetic biology company, Camena Bioscience, recently announced the closing of a USD 10 million Series A financing round, led by Mercia, a UK-based venture capital firm. Camena aims to scale operations and continue developing gSynth, its enzyme-based DNA synthesis platform.

 

Global DNA Synthesizer Market Segmentations

Market Breakup by Type

  • Benchtop DNA Synthesizers 
  • Large-scale DNA Synthesizers

 

Market Breakup by Application

  • Research and Development
  • Academic 
  • Industrial
  • Diagnosis
  • Therapeutics

 

Market Breakup by End User

  • Biopharmaceutical Companies 
  • Academic and Research Institutes 
  • Contract Research Organizations

 

Market Breakup by Region

  • North America
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Global DNA Synthesizer Market Overview

The growth of the market is expected to be driven by the increasing demand for efficient DNA synthesizers from life science laboratories and pharmaceutical and biotechnology companies. Another key factor is the rapid developments in genomics and life sciences, boosting the market growth further. The increasing significance of DNA synthesizers in synthetic and molecular biology is also supporting the market growth. The market is also experiencing high demand for nucleic acid synthesis platforms among several end users, further propelling the global DNA synthesizer market growth.

 

The increasing technological advancements are also a key factor driving the global market. The proven efficacy of benchtop DNA synthesizers as they increase the speed and efficiency of research in academic and industrial labs is contributing to the increased demand in the market, further expected to boost the growth of the market in the coming years.

 

The efforts to lower the cost of synthesizing DNA oligonucleotides and commercialize scalable DNA synthesizers are continuously increasing. Significant progress has been made towards the goal of affordable DNA synthesis with microfluidic/microarray oligonucleotide synthesis methods and improvements in synthetic DNA quality.

 

Furthermore, ongoing advancements in other efficient synthesis technologies are also expected to make synthesizers widely available at lower costs, adding further value to the global DNA synthesizer market share.

 

North America is currently leading the global market and is expected to keep leading throughout the forecast period due to the presence of several key players in the market and their continuous developments. Moreover, the market is also driven by ongoing technological advancements, increased investment in research and development activities, and growing demand for innovative synthesizers.

 

Global DNA Synthesizer Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • LGC Biosearch Technologies 
  • Bioneer Corporation  
  • Thermo Fisher Scientific, Inc.  
  • IBA GmbH  
  • Twist Bioscience  
  • Eton Bioscience  
  • Quintara Biosciences  
  • Eurofins Scientific 
  • Integrated DNA Technologies, Inc 
  • Integrated DxNA Technologies, Inc

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • End User
  • Region
Breakup by Type
  • Benchtop DNA Synthesizers
  • Large-scale DNA Synthesizers
Breakup by Application
  • Research and Development
  • Academic
  • Industrial
  • Diagnosis
  • Therapeutics 
Breakup by End User
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • LGC Biosearch Technologies
  • Bioneer Corporation
  • Thermo Fisher Scientific, Inc.
  • IBA GmbH
  • Twist Bioscience
  • Eton Bioscience
  • Quintara Biosciences
  • Eurofins Scientific
  • Integrated DNA Technologies, Inc
  • Integrated DxNA Technologies, Inc

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global DNA Synthesizer Market Overview
 
    3.1    Global DNA Synthesizer Market Historical Value (2017-2023) 
    3.2    Global DNA Synthesizer Market Forecast Value (2024-2032)
4    Global DNA Synthesizer Market Landscape
    4.1    DNA Synthesizer: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    DNA Synthesizer: Product Landscape
        4.2.1    Analysis by Application
        4.2.2    Analysis by Type
        4.2.3    Analysis by End User
5    Global DNA Synthesizer Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global DNA Synthesizer Market Segmentation
    6.1    Global DNA Synthesizer Market by Type
        6.1.1    Market Overview
        6.1.2    Benchtop DNA Synthesizers
        6.1.3    Large-scale DNA Synthesizers
    6.2    Global DNA Synthesizer Market by Application
        6.2.1    Market Overview
        6.2.2    Research and Development
        6.2.3    Academic
        6.2.4    Industrial
        6.2.5    Diagnosis
        6.2.6    Therapeutics 
    6.3    Global DNA Synthesizer Market by End User
        6.3.1    Market Overview
        6.3.2    Biopharmaceutical Companies
        6.3.3    Academic and Research Institutes
        6.3.4    Contract Research Organizations
    6.4    Global DNA Synthesizer Market by Region
        6.4.1    Market Overview
        6.4.2    North America
        6.4.3    Europe 
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America DNA Synthesizer Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe DNA Synthesizer Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific DNA Synthesizer Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America DNA Synthesizer Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa DNA Synthesizer Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    LGC Biosearch Technologies 
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications 
    17.2    Bioneer Corporation 
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Thermo Fisher Scientific, Inc. 
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    IBA GmbH 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Twist Bioscience 
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Eton Bioscience 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Quintara Biosciences 
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Eurofins Scientific
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Integrated DNA Technologies, Inc
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Integrated DxNA Technologies, Inc
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 261.06 million in 2023, driven by the increasing research and development activities.

The market is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032, likely to reach a market value of USD 876.14 million by 2032.

The rapidly advancing healthcare infrastructure, rising investment by the governments and leading organisations, and the increasing demand for innovative synthesizers are among the key factors driving the market growth.

The companies investing heavily in research activities for new developments in the segment is a major trend influencing the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The major types of synthesizers include benchtop DNA synthesizers and large-scale DNA synthesizers.

DNA synthesizers find wide applications in research and development, academic, industrial, diagnosis, therapeutics sector.

The end-users of the synthesizers include contract research organizations, biopharmaceutical companies, academic and research institutes.

Key players involved in the market are LGC Biosearch Technologies, Bioneer Corporation, Thermo Fisher Scientific, Inc., IBA GmbH, Twist Bioscience, Eton Bioscience, Quintara Biosciences, Integrated DNA Technologies, Inc, Integrated DxNA Technologies, Inc., and Eurofins Scientific.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER